Edition:
India

Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

13.73USD
1:30am IST
Change (% chg)

$2.66 (+24.03%)
Prev Close
$11.07
Open
$11.68
Day's High
$14.00
Day's Low
$11.45
Volume
1,302,700
Avg. Vol
401,485
52-wk High
$14.00
52-wk Low
$1.48

Latest Key Developments (Source: Significant Developments)

Arrowhead Pharmaceuticals Presents Preclinical Data On Expanding Cardiometabolic Pipeline
Friday, 11 May 2018 

May 11 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS PRESENTS PRECLINICAL DATA ON EXPANDING CARDIOMETABOLIC PIPELINE.ARROWHEAD PHARMACEUTICALS - INTENDS TO FILE CLINICAL TRIAL APPLICATIONS FOR ARO-ANG3 & ARO-APOC3 BEFORE END OF 2018.  Full Article

Arrowhead Pharmaceuticals Reports Qtrly Loss Per Share $0.18
Wednesday, 9 May 2018 

May 8 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS REPORTS FISCAL 2018 SECOND QUARTER RESULTS.QTRLY LOSS PER SHARE $0.18.Q2 EARNINGS PER SHARE VIEW $-0.19 -- THOMSON REUTERS I/B/E/S.  Full Article

Arrowhead Pharmaceuticals Announces Pricing Of Underwritten Public Offering Of Common Stock
Thursday, 18 Jan 2018 

Jan 18 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS ANNOUNCES PRICING OF UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 10.0 MILLION COMMON SHARES PRICED AT $5.25PER SHARE.  Full Article

Arrowhead Pharma Announces Proposed Underwritten Offering Of Common Stock
Thursday, 18 Jan 2018 

Jan 17 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS ANNOUNCES PROPOSED UNDERWRITTEN OFFERING OF COMMON STOCK.  Full Article

Silence Therapeutics ‍Sells Further Stake In Arrowhead Pharmaceuticals ​
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - Silence Therapeutics Plc ::‍SOLD A FURTHER PART OF ITS HOLDING OF COMMON SHARES IN ARROWHEAD PHARMACEUTICALS INC.​.DEAL ‍FOR A TOTAL CONSIDERATION OF $11.3 MILLION​.  Full Article

Arrowhead Pharmaceuticals Files For Regulatory Clearance To Begin Phase 1 Study Of ARO-AAT
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS FILES FOR REGULATORY CLEARANCE TO BEGIN PHASE 1 STUDY OF ARO-AAT.ARROWHEAD PHARMACEUTICALS INC - APPLICATION FOR APPROVAL OF CLINICAL TRIAL WAS SUBMITTED TO NEW ZEALAND MEDICINES AND MEDICAL DEVICES SAFETY AUTHORITY.  Full Article

Silence Therapeutics Cuts Stake In Arrowhead Pharma To 3.7 Pct From 6.4 Pct
Saturday, 9 Dec 2017 

Dec 8 (Reuters) - Arrowhead Pharmaceuticals Inc ::SILENCE THERAPEUTICS PLC CUTS STAKE IN ARROWHEAD PHARMACEUTICALS TO 3.7 PERCENT AS OF DECEMBER 8 FROM A STAKE OF 6.4 PERCENT AS OF NOVEMBER 29 - SEC FILING.  Full Article

Silence Therapeutics Plc Reports 6.4 Pct Stake In Arrowhead Pharmaceuticals As Of Nov 29
Saturday, 2 Dec 2017 

Dec 1 (Reuters) - Arrowhead Pharmaceuticals Inc ::SILENCE THERAPEUTICS PLC REPORTS 6.4 PERCENT STAKE IN ARROWHEAD PHARMACEUTICALS INC AS OF NOVEMBER 29 - SEC FILING.SILENCE THERAPEUTICS SAYS ACQUIRED ARROWHEAD PHARMACEUTICALS' COMMON STOCK IN ORDER TO FACILITATE DISCUSSIONS REGARDING POSSIBLE TRANSACTION WITH THEM.  Full Article

Arrowhead Pharmaceuticals files for mixed shelf of up to $200 mln - SEC filing
Saturday, 29 Oct 2016 

Arrowhead Pharmaceuticals Inc :Files for mixed shelf of up to $200 million - SEC filing.  Full Article

Arrowhead Pharma files for sale of aggregate of 3 mln shares of co's common stock by selling shareholder Amgen
Saturday, 29 Oct 2016 

Amgen Inc : Arrowhead Pharmaceuticals Inc - Files for sale of aggregate of 3.0 million shares of co's common stock by selling shareholder Amgen Inc - SEC filing .Arrowhead Pharmaceuticals Inc - Co will not receive any proceeds from sale by selling stockholders of shares.  Full Article